Zinc could be key to new diabetes treatments
Researchers at the University of St Andrews say a greater understanding of how zinc is handled in our body could lead to improved treatments for people with diabetes.
Mar 1, 2021
0
263
Researchers at the University of St Andrews say a greater understanding of how zinc is handled in our body could lead to improved treatments for people with diabetes.
Mar 1, 2021
0
263
Coronavirus survivors have twice the risk of developing dangerous blood clots that travel to their lungs compared to people who weren't infected, as well double the chance of respiratory symptoms, a large new study said Tuesday.
May 25, 2022
1
10
People with blood types A and B may have higher risks for developing dangerous blood clots compared to people who have type O blood. That's according to new research that also showed a slightly higher risk for certain types ...
Jan 23, 2020
0
1368
Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published ...
Nov 23, 2022
0
33
Older stroke patients who had a history of COVID-19 were more likely to develop dangerous blood clots in the veins than those who did not have the coronavirus-driven disease, a new study from the Centers for Disease Control ...
Feb 4, 2022
1
62
(HealthDay)—Following COVID-19 hospitalization, thromboembolic events occur frequently, according to a study published online April 6 in Blood.
Apr 12, 2021
0
7
In a fortuitous case of mistaken chemical identity, a team of Georgia Tech bioengineers has discovered a promising new way to treat dangerous blood clots without the potentially harmful side effects of other clot-busting ...
Apr 22, 2021
1
166
"Don't poke the bear," they said. But that's exactly what a team of scientists have been doing to discover the secrets of blood clotting.
Apr 13, 2023
0
16
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory ...
Jul 28, 2020
0
6
(HealthDay)—Hospitalized COVID-19 patients face an increased risk of developing dangerous blood clots, a new review indicates.
Oct 6, 2020
0
2